By Dani Kass ( February 18, 2016, 5:44 PM EST) -- A Pennsylvania district court acted properly in dismissing a diabetes patient's failure-to-warn suit against GlaxoSmithKline LLC, which was part of multidistrict litigation over side effects from the drug Avandia, because her doctor said he would have prescribed the drug even if he knew the possible harms, the Third Circuit ruled....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.